Anastrozole and Cabergoline Interaction
Anastrozole and Cabergoline have a synergistic interaction with 65% confidence. Cabergoline supports hormonal recovery from suppression caused by Anastrozole. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life. Both compounds affect the gonads and pituitary, so monitoring these systems is recommended.
Compound Profiles
Anastrozole
Aromatase Inhibitor | Estrogen Management
Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.
View full profileCabergoline
Dopamine Agonist | Prolactin Management
Cabergoline exerts its effects by acting as a potent agonist at dopamine D2 receptors on lactotroph cells in the anterior pituitary gland. Prolactin secretion is tonically inhibited by hypothalamic dopamine acting on these D2 receptors, and cabergoline mimics this inhibitory signal with high affinity and prolonged duration.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Anastrozole with Cabergoline?
Yes, Anastrozole and Cabergoline can generally be taken together. Cabergoline supports hormonal recovery from suppression caused by Anastrozole. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life.
Is Anastrozole and Cabergoline safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: pct agent. Monitor accordingly.
What are the interactions between Anastrozole and Cabergoline?
Cabergoline supports hormonal recovery from suppression caused by Anastrozole. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life. This assessment has 65% confidence and is inferred from pharmacological mechanism analysis.
How should I time Anastrozole and Cabergoline?
Anastrozole has a half-life of ~40-50 hours and Cabergoline has a half-life of ~63-69 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.